Subscribe to Newsletter
Business & Profession Other

Shortsighted Scholars

| Mark Hillen

Is the potential dystopia that is myopia a consequence of too much study?

Subspecialties Retina

The battle for hearts and minds

| Mark Hillen

Population-level disease prophylaxis with statins has improved the lives of millions. But there has been some protest about this mass medication. Is the next battle not with disease, but with the press?

Subspecialties Retina

Recurrent Diabetic Macular Edema: What to Do?

One of the most debilitating microvascular complications of diabetes is diabetic retinopathy, the most important cause of blindness among working age adults in developed countries.

Subspecialties Retina

The Chelsea Challenge: Managing Refractory Diabetic Macular Edema

As the prevalence of diabetes increases worldwide, so too do the complications relating to it, such as diabetic macular edema (DME).

Subspecialties Retina

Managing Longstanding Refractory Diabetic Macular Edema

Diabetic macular edema (DME) poses a significant management dilemma for visual impairment.

Subspecialties Retina

Treating Long-Lasting Diabetic Macular Edema

Diabetic macular edema (DME) may occur when blood vessels leak contents into the macular region.

Subspecialties Retina

Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A Case Report

| Sponsored by Alimera

Diabetic maculopathy is the most common cause of visual impairment in individuals with diabetes.

Business & Profession Refractive

Is this Femto’s Killer App?

| Anita Nevyas-Wallace

Dramatic improvements in the results from an astigmatic keratotomy model suggest that the femtosecond laser may be more than a rich ophthalmologist’s toy after all.

Subspecialties Cornea / Ocular Surface

Benchmarking Keratoconus

| Mark Hillen

What does analysis of the last five years of the literature on keratoconus tell us about the priorities of the field and the major contributors to it?

Business & Profession Professional Development

He Will Deliver

Sitting Down With Dirk Sauer, Novartis’ Global Head, Development Franchise Ophthalmics.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: